Projected Income Statement: Safran

Forecast Balance Sheet: Safran

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 1,544 -14 -374 -1,738 -1,738 -3,634 -5,156 -7,330
Change - -100.91% -2,571.43% -364.71% 0% -109.09% -41.88% -42.16%
Announcement Date 24/02/22 17/02/23 15/02/24 14/02/25 12/02/26 - - -
1EUR in Million
Estimates

Cash Flow Forecast: Safran

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 387 498 823 1,044 1,238 1,700 1,802 1,730
Change - 28.68% 65.26% 26.85% 18.58% 37.32% 6.02% -4%
Free Cash Flow (FCF) 1 1,680 2,666 2,945 3,189 3,921 4,540 4,726 5,368
Change - 58.69% 10.47% 8.29% 22.95% 15.77% 4.12% 13.57%
Announcement Date 24/02/22 17/02/23 15/02/24 14/02/25 12/02/26 - - -
1EUR in Million
Estimates

Forecast Financial Ratios: Safran

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 18.21% 19.26% 19.82% 19.82% 22.39% 21.71% 21.88% 22.13%
EBIT Margin (%) 11.83% 12.65% 13.65% 15.08% 16.59% 17.19% 17.63% 18%
EBT Margin (%) 1.76% -16.39% 20.5% -3.14% 32.78% 16.89% 17.2% 18.39%
Net margin (%) 0.28% -12.92% 14.85% -2.44% 22.91% 11.84% 12.61% 13.25%
FCF margin (%) 11.01% 14.01% 12.69% 11.67% 12.52% 12.76% 12.13% 12.8%
FCF / Net Income (%) 3,906.98% -108.42% 85.51% -478.11% 54.63% 107.81% 96.2% 96.55%

Profitability

        
ROA 1.87% 2.66% 4.17% 5.82% 5.43% 6.38% 7.44% 7.87%
ROE 6.03% 10.13% 18.45% 28.21% 25.38% 25.25% 28.14% 28.74%

Financial Health

        
Leverage (Debt/EBITDA) 0.56x - - - - - - -
Debt / Free cash flow 0.92x - - - - - - -

Capital Intensity

        
CAPEX / Current Assets (%) 2.54% 2.62% 3.55% 3.82% 3.95% 4.78% 4.63% 4.12%
CAPEX / EBITDA (%) 13.93% 13.58% 17.9% 19.29% 17.65% 22.01% 21.15% 18.64%
CAPEX / FCF (%) 23.04% 18.68% 27.95% 32.74% 31.57% 37.45% 38.13% 32.23%

Items per share

        
Cash flow per share 1 5.535 8.054 9.899 11.25 13.69 14.48 16.44 18.23
Change - 45.5% 22.9% 13.65% 21.7% 5.79% 13.5% 10.91%
Dividend per Share 1 0.5 1.35 1.35 2.9 3.35 4.03 4.928 5.536
Change - 170% 0% 114.81% 15.52% 20.31% 22.26% 12.35%
Book Value Per Share 1 30.09 24.52 26.84 24.19 35.51 34.61 43.27 45.81
Change - -18.5% 9.44% -9.88% 46.81% -2.53% 25% 5.87%
EPS 1 0.1 -5.76 8.07 -1.6 17.17 9.965 11.75 13.2
Change - -5,860% 240.1% -119.83% 1,173.12% -41.96% 17.9% 12.38%
Nbr of stocks (in thousands) 426,262 426,828 417,625 416,751 417,373 415,466 415,466 415,466
Announcement Date 24/02/22 17/02/23 15/02/24 14/02/25 12/02/26 - - -
1EUR
Estimates
2026 *2027 *
P/E ratio 31.9x 27x
PBR 9.18x 7.34x
EV / Sales 3.61x 3.26x
Yield 1.27% 1.55%

EPS & Dividend

Y-o-Y evolution of P/E

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
317.70EUR
Average target price
356.29EUR
Spread / Average Target
+12.15%

Quarterly revenue - Rate of surprise